Advertisement
Screener

Picard Medical, Inc. (PMI) Graph

2.0 / 5 stars · 2/5 Roast Me

Add as a preferred source on Google

PMI Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $2.95M; Cost of revenue $2.34M; Research and development $1.37M; Selling, general and administrative $3.87M.
  • 2026-03-31: Revenue $1.15M; Cost of revenue $875.00K; Research and development $1.90M; Selling, general and administrative $2.89M.
  • 2025-09-30: Revenue $1.19M; Cost of revenue $1.32M; Research and development $951.00K; Selling, general and administrative $2.41M.
  • 2025-06-30: Revenue $2.13M; Cost of revenue $2.26M; Research and development $743.00K; Selling, general and administrative $2.65M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

PMI revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Product$2.94MRentals$19.00KRevenue$2.95MCost of revenue$2.34MGross profit$616.00KOperating expenses$5.24MOperating income-$4.63MOther income, net$13.00KResearch & development$1.37MSelling, general& administrative$3.87MPre-tax income-$5.65MIncome tax$7.00KNet income-$5.66M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$2.95M$2.34M$1.37M$3.87M$5.25M$7.00K-$5.66M
2026-03-31$1.15M$875.00K$1.90M$2.89M$4.79M$0.00-$7.62M
2025-09-30$1.19M$1.32M$951.00K$2.41M$3.36M$0.00-$10.43M
2025-06-30$2.13M$2.26M$743.00K$2.65M$3.39M$0.00-$6.72M
2025-03-31$620.00K$978.00K$808.00K$2.08M$2.89M$31.00K-$5.56M
2024-09-30$881.00K$1.55M$961.00K$2.81M$3.77M$0.00-$6.21M
2024-06-30$694.00K$1.08M$940.00K$2.50M$3.44M(m)-$4.06M
2024-03-31(m)(m)(m)(m)(m)(m)-$1.95M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$4.10M$3.21M$3.27M$6.76M$10.03M$7.00K-$13.28M
2025-06-30$2.74M$3.23M$1.55M$4.73M$6.28M$31.00K-$12.29M
2024-06-30$2.67M(m)$1.63M$4.49M$6.12M(m)-$6.01M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$3.93M$4.55M$2.50M$7.14M$9.64M$31.00K-$22.71M
2024-09-30$3.56M$3.80M$2.59M$7.30M$9.89M$0.00-$12.22M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$4.94M$5.14M$3.05M$10.00M$13.05M$35.00K-$27.00M
2024-12-31$4.39M$4.50M$3.38M$10.22M$13.60M-$15.00K-$21.05M

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)United States$0.012B
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10
CERENOME, INC. (CNSY)United States$0.014B
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Advertisement